Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Shanshan Ran, Dashan Zheng
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
openalex
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
The rising global burden of MASLD and other metabolic diseases (2000-2021)
10.1002/ueg2.70072 · 2025
Mechanisms and disease consequences of nonalcoholic fatty liver disease
10.1016/j.cell.2021.04.015 · 2021
Integrating the environmental and genetic architectures of aging and mortality
10.1038/s41591-024-03483-9 · 2025
Environmental risk factors for liver cancer and nonalcoholic fatty liver disease
10.1007/s40471-019-0183-2 · 2019
Air pollution deaths attributable to fossil fuels: observational and modelling study
10.1136/bmj-2023-077784 · 2023
Mapping the association between environmental pollutants and steatotic liver disease: a systematic review and meta-analysis
10.1016/j.envres.2025.122623 · 2025
A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures
10.1038/s42255-023-00775-1 · 2023
Dissecting metabolic dysfunction- and alcohol-associated liver disease (MetALD) using proteomic and metabolomic profiles
10.1016/j.jhep.2025.05.026 · 2025
Subacute PM2.5 exposure induces hepatic insulin resistance through inflammation and oxidative stress
2025
Air pollution and systemic inflammation in patients with suspected OSA living in an urban residential area
10.1016/j.chest.2020.05.596 · 2020
Association of metabolic signatures of air pollution with MASLD: observational and mendelian randomization study
10.1016/j.jhep.2024.09.033 · 2025
Large-scale plasma proteomics uncovers novel targets linking ambient air pollution and depression
10.1038/s41380-025-02953-x · 2025
Plasma proteome mediates the associations between air pollution exposure and disease risk
2026
Revisiting biomarker discovery by plasmaproteomics
10.15252/msb.20156297 · 2017
Noninvasive proteomic biomarkers for alcohol-related liver disease
10.1038/s41591-022-01850-y · 2022
Multi-omics profiling reveals altered mitochondrial metabolism in adipose tissue from patients with metabolic dysfunction-associated steatohepatitis
10.1016/j.ebiom.2024.105532 · 2025
Mechanisms of NAFLD development and therapeutic strategies
10.1038/s41591-018-0104-9 · 2018
Plasma proteome profiling discovers novel proteins associated with non-alcoholic fatty liver disease
10.15252/msb.20188793 · 2019
Plasma proteomic associations with genetics and health in the UK Biobank
10.1038/s41586-023-06592-6 · 2023
Proteomic signature of dementia risk in type 2 diabetes
2025
Alzheimer's Disease polygenic risk, the plasma proteome, and dementia incidence among UK older adults
10.1007/s11357-024-01413-8 · 2025
Quality control and removal of technical variation of NMR metabolic biomarker data in ∼120,000 UK Biobank participants
10.1038/s41597-023-01949-y · 2023
Exposure to air pollution during pre-hypertension and subsequent hypertension, cardiovascular disease, and death: a trajectory analysis of the UK biobank cohort
10.1289/ehp10967 · 2023
Disconnection of network hubs and cognitive impairment after traumatic brain injury
10.1093/brain/awv075 · 2015
Metabolic signature of healthy lifestyle and risk of rheumatoid arthritis: observational and mendelian randomization study
10.1016/j.ajcnut.2023.04.034 · 2023
The Mediterranean diet, plasma metabolome, and cardiovascular disease risk
10.1093/eurheartj/ehaa209 · 2020
Steroid receptor coactivator-1 facilitates METTL3-mediated m6A modification by coactivating NF-kappaB and promotes the malignant progression of glioblastoma
10.1038/s41388-025-03494-x · 2025
Biomass fuel induces neuroinflammation and neurodegeneration via the astrocyte-microglia IL-17A/IL-17RA pathway
10.1016/j.jhazmat.2025.138569 · 2025
Prolonged PM2.5 exposure elevates risk of oxidative stress-driven nonalcoholic fatty liver disease by triggering increase of dyslipidemia
10.1016/j.freeradbiomed.2018.11.016 · 2019
Chemokines and chemokine receptors in the development of NAFLD
10.1007/978-981-10-8684-7_4 · 2018
Integrated profiling of adiponectin and cytokine signaling pathways in high-fat diet-induced MASLD reveals early markers of disease progression
10.1038/s41598-025-02001-2 · 2025
Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2
10.1152/ajpgi.00365.2011 · 2012
CC chemokine ligand 3 deficiency ameliorates diet-induced steatohepatitis by regulating liver macrophage recruitment and M1/M2 status in mice
10.1016/j.metabol.2021.154914 · 2021
Interleukin-22 ameliorates neutrophil-driven nonalcoholic steatohepatitis through multiple targets
10.1002/hep.31031 · 2020
Associations of exposure to fine particulate matter mass and constituents with systemic inflammation: a cross-sectional study of urban older adults in China
10.1021/acs.est.1c04488 · 2022
The acute effects of fine particulate matter constituents on blood inflammation and coagulation
10.1021/acs.est.7b00312 · 2017
10.20944/preprints202205.0252.v1
10.20944/preprints202205.0252.v1
MMP-9 deficiency shelters endothelial PECAM-1 expression and enhances regeneration of steatotic livers after ischemia and reperfusion injury
10.1016/j.jhep.2013.12.022 · 2014
Genome-wide enhancer-gene regulatory maps of liver reveal novel regulatory mechanisms underlying NAFLD pathogenesis
10.1186/s12864-025-11668-w · 2025
Exposure to ambient air pollution and elevated blood levels of gamma-glutamyl transferase in a large Austrian cohort
10.1016/j.scitotenv.2023.163658 · 2023
Multi-omics reveals hypertrophy of adipose tissue and lipid metabolism disorder via mitochondria in young mice under real-ambient exposure to air pollution
10.3389/fphar.2023.1122615 · doi-reference
PM2.5 induces liver fibrosis via triggering ROS-mediated mitophagy
10.1016/j.ecoenv.2018.08.050 · doi-reference
10.1021/acssensors.0c01524
10.1021/acssensors.0c01524 · doi-reference
The paraoxonase (PON) gene family in health, metabolic dysfunction-associated steatotic liver disease (MASLD) and other diseases
10.3390/ijms262211054 · doi-reference
Neuregulin1 ameliorates metabolic dysfunction-associated fatty liver disease via the ERK/SIRT1 signaling pathways
10.1186/s12876-025-03632-5 · doi-reference
High-density lipoprotein modifications: a pathological consequence or cause of disease progression?
10.3390/biomedicines8120549 · doi-reference
Non-alcoholic fatty liver disease and cardiovascular risk: pathophysiological mechanisms and implications
10.1016/j.jhep.2016.04.005 · doi-reference
Metabolic regulation of the immune system in health and diseases: mechanisms and interventions
10.1038/s41392-024-01954-6 · doi-reference
Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases
10.1016/j.cmet.2017.08.002 · doi-reference
The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes
10.1038/nature13478 · doi-reference
IKK-beta links inflammation to obesity-induced insulin resistance
10.1038/nm1185 · doi-reference
Proteomic profiling of plasma to uncover novel intervention targets and prognostic biomarkers for chronic liver diseases
10.1111/dom.70696 · doi-reference
Disturbance of mitochondrial functions caused by N-acetylglutamate and N-acetylmethionine in brain of adolescent rats: potential relevance in aminoacylase 1 deficiency
10.1016/j.neuint.2023.105631 · doi-reference
Increased Tim-3 expression alleviates liver injury by regulating macrophage activation in MCD-induced NASH mice
10.1038/s41423-018-0032-0 · doi-reference
Granulocyte colony stimulating factor treatment in non-alcoholic fatty liver disease: beyond marrow cell mobilization
10.18632/oncotarget.18967 · doi-reference
Analysis of the genetic relationship between atherosclerosis and non-alcoholic fatty liver disease through biological interaction networks
10.3390/ijms24044124 · doi-reference
CD28 ligation in the absence of TCR stimulation up-regulates IL-17A and pro-inflammatory cytokines in relapsing-remitting multiple sclerosis T lymphocytes
10.1016/j.imlet.2013.12.020 · doi-reference
Inhibition of DDR1 potentiates carbon ion radiotherapy by promoting ferroptosis and immunogenic death in head and neck squamous cell carcinoma
10.1186/s12967-025-07062-5 · doi-reference
Hesperidin ameliorates hepatocyte cell cycle disruption, apoptosis, and necroptosis in mice with nonalcoholic fatty liver disease via the VEGFA-PI3K/AKT pathway
10.1016/j.intimp.2025.115304 · doi-reference